These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22233734)

  • 1. Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: a novel and potential antifolate lead for Pf-DHFR-TS inhibition.
    Gahtori P; Ghosh SK; Parida P; Prakash A; Gogoi K; Bhat HR; Singh UP
    Exp Parasitol; 2012 Mar; 130(3):292-9. PubMed ID: 22233734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
    Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH
    Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives.
    Bhat HR; Singh UP; Thakur A; Kumar Ghosh S; Gogoi K; Prakash A; Singh RK
    Exp Parasitol; 2015 Oct; 157():59-67. PubMed ID: 26164360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives against pf-DHFR-TS.
    Sahu S; Ghosh SK; Kalita J; Dutta M; Bhat HR
    Exp Parasitol; 2016 Apr; 163():38-45. PubMed ID: 26821296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents.
    Kumar A; Srivastava K; Kumar SR; Siddiqi MI; Puri SK; Sexana JK; Chauhan PM
    Eur J Med Chem; 2011 Feb; 46(2):676-90. PubMed ID: 21194812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor.
    Sahu S; Ghosh SK; Gahtori P; Pratap Singh U; Bhattacharyya DR; Bhat HR
    Pharmacol Rep; 2019 Oct; 71(5):762-767. PubMed ID: 31351317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
    Fogel GB; Cheung M; Pittman E; Hecht D
    J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites.
    Bhat HR; Singh UP; Gahtori P; Ghosh SK; Gogoi K; Prakash A; Singh RK
    Chem Biol Drug Des; 2015 Sep; 86(3):265-71. PubMed ID: 25487527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and development of novel N-(4-aminobenzoyl)- l-glutamic acid conjugated 1,3,5-triazine derivatives as Pf-DHFR inhibitor: An in-silico and in-vitro study.
    Adhikari N; Choudhury AAK; Shakya A; Ghosh SK; Patgiri SJ; Singh UP; Bhat HR
    J Biochem Mol Toxicol; 2023 Apr; 37(4):e23290. PubMed ID: 36541419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expeditious synthesis and biological evaluation of novel 2,N6-disubstituted 1,2-dihydro-1,3,5-triazine-4,6-diamines as potential antimalarials.
    Gravestock D; Rousseau AL; Lourens AC; Moleele SS; van Zyl RL; Steenkamp PA
    Eur J Med Chem; 2011 Jun; 46(6):2022-30. PubMed ID: 21420762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shape- and chemical feature-based 3D-pharmacophore model generation and virtual screening: identification of potential leads for P. falciparum DHFR enzyme inhibition.
    Adane L; Patel DS; Bharatam PV
    Chem Biol Drug Des; 2010 Jan; 75(1):115-26. PubMed ID: 19895504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative structure activity relationship study of 2,4,6-trisubstituted-s-triazine derivatives as antimalarial inhibitors of Plasmodium falciparum dihydrofolate reductase.
    Ojha H; Gahlot P; Tiwari AK; Pathak M; Kakkar R
    Chem Biol Drug Des; 2011 Jan; 77(1):57-62. PubMed ID: 20958921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
    Hekmat-Nejad M; Rathod PK
    Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of 6-aryl-1,6-dihydro-1,3,5-triazine-2,4-diamines as antiplasmodial antifolates.
    Lourens AC; Gravestock D; van Zyl RL; Hoppe HC; Kolesnikova N; Taweechai S; Yuthavong Y; Kamchonwongpaisan S; Rousseau AL
    Org Biomol Chem; 2016 Aug; 14(33):7899-911. PubMed ID: 27477595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antimalarial activity and molecular docking analysis of 4-aminoquinoline-clubbed 1,3,5-triazine derivatives.
    Bhat HR; Ghosh SK; Prakash A; Gogoi K; Singh UP
    Lett Appl Microbiol; 2012 May; 54(5):483-6. PubMed ID: 22394198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy.
    Mukherjee P; Pradhan A; Shah F; Tekwani BL; Avery MA
    Bioorg Med Chem; 2008 May; 16(9):5254-65. PubMed ID: 18362073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.
    Adane L; Bharatam PV
    J Mol Graph Model; 2009 Nov; 28(4):357-67. PubMed ID: 19796975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 2-[3,5-substituted pyrazol-1-yl]-4,6-trisubstituted triazine derivatives as antimalarial agents.
    Katiyar SB; Srivastava K; Puri SK; Chauhan PM
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4957-60. PubMed ID: 16168643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure-activity relationships for cycloguanil analogs as PfDHFR inhibitors using mathematical molecular descriptors.
    Basak SC; Mills D
    SAR QSAR Environ Res; 2010 Apr; 21(3-4):215-29. PubMed ID: 20544548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors.
    Nirmalan N; Sims PF; Hyde JE
    Mol Biochem Parasitol; 2004 Jul; 136(1):63-70. PubMed ID: 15138068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.